Anew Labs
PrivateLast Round
Series A
Sep 16, 2026
Est. Valuation
$1.5B
Total Funding Raised
$290M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Anew Labs operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in September 2026.
Anew Labs is a biotechnology company that develops AI-powered drug discovery platforms for protein structure prediction, molecule generation, and antibody design.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anew Labs Comparables
Compare Anew Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altos Labs | 79% | |
| BioAge Labs | 78% | |
| Retro Biosciences | 78% |
For institutional investors. Book with your work email.
Anew Labs Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Anew Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series A |
| Boyu Capital | Series A |
| Hillhouse Investment | Series A |
| Shanghai State-owned Capital Investment | Series A |
| 5Y Capital | Series A |
| Primavera Venture Partners | Series A |
| HongShan Capital Group (HSG) | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
$290M round with participation from Boyu Capital and Hillhouse Investment.
For institutional investors. Book with your work email.
Anew Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anew Labs's valuation, stock price, and market status.
Is Anew Labs a public or private company?
Anew Labs is a private company.
What is the current stock price of Anew Labs?
Anew Labs is a private company, so its shares have no public market price. Caplight tracks Anew Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anew Labs worth (valuation)?
Anew Labs's valuation is estimated at $1.5B based on funding round data.
Can I buy Anew Labs stock?
Anew Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anew Labs's last funding round?
Anew Labs's most recent funding round was Series A on September 16, 2026.
Who are the main investors in Anew Labs?
Key investors in Anew Labs include IDG Capital, Boyu Capital, Hillhouse Investment, Shanghai State-owned Capital Investment, 5Y Capital.
Will Anew Labs IPO soon?
No public IPO plans have been announced for Anew Labs.
How can I track Anew Labs secondary market activity?
Caplight tracks bids, offers, and trades in Anew Labs's shares on secondary markets.